- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速下跌的趋势。
- 长期趋势：
已有50家主力机构披露2025-12-31报告期持股数据，持仓量总计1.41亿股，占流通A股47.72%
- 波段诊断：
-
技术面诊股
诊断结果：3.7技术面打败了21%的股票
技术面评分前10的股票
近期的平均成本为6.94元。空头行情中，并且有加速下跌的趋势。
平均成本
近期的平均成本为6.94元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"6.94","date":1781150119,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2026.06.11","stock":"-0.71","trade":"-1.24","ind":"-0.16"},{"date":"2026.06.10","stock":"-0.14","trade":"-0.14","ind":"-0.42"},{"date":"2026.06.09","stock":"0.14","trade":"0.45","ind":"1.28"},{"date":"2026.06.08","stock":"-2.88","trade":"-2.49","ind":"-1.70"},{"date":"2026.06.05","stock":"2.54","trade":"0.25","ind":"-0.74"},{"date":"2026.06.04","stock":"-2.87","trade":"-1.80","ind":"-0.64"},{"date":"2026.06.03","stock":"-1.88","trade":"-1.10","ind":"0.22"},{"date":"2026.06.02","stock":"-4.12","trade":"-2.06","ind":"0.43"},{"date":"2026.06.01","stock":"3.88","trade":"0.40","ind":"-0.27"},{"date":"2026.05.29","stock":"-1.06","trade":"0.36","ind":"-0.73"},{"date":"2026.05.28","stock":"0.13","trade":"-0.71","ind":"0.12"},{"date":"2026.05.27","stock":"-2.71","trade":"-1.05","ind":"-1.25"},{"date":"2026.05.26","stock":"-2.02","trade":"-1.43","ind":"-0.17"},{"date":"2026.05.25","stock":"-1.74","trade":"-1.35","ind":"0.96"},{"date":"2026.05.22","stock":"1.77","trade":"0.11","ind":"0.87"},{"date":"2026.05.21","stock":"-3.41","trade":"-1.67","ind":"-2.04"},{"date":"2026.05.20","stock":"-2.38","trade":"-0.92","ind":"-0.18"},{"date":"2026.05.19","stock":"1.45","trade":"0.64","ind":"0.92"},{"date":"2026.05.18","stock":"0.12","trade":"-1.49","ind":"-0.09"},{"date":"2026.05.15","stock":"-1.43","trade":"-0.71","ind":"-1.02"},{"date":"2026.05.14","stock":"-0.83","trade":"-1.71","ind":"-1.52"}]
汉商集团,上证指数,化学制药指数
压力支撑
该股压力位为6.94元，支撑位为6.79元。
[{"text":"\u538b\u529b\u4f4d","value":"6.94","date":1781107200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"6.79","date":1781107200,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：6.5资金面打败了91%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：06月12日 12:31
| 机构今日流向(万元) | -420.67 | 机构5日流向(万元) | -2643.61 |
| 机构10日流向(万元) | -6089.30 | 机构20日流向(万元) | -23080.07 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量增加384.47万股，其中基金净增仓4家，主力净增仓32家，有一定的中长期投资价值。
截止2025-12-31，共50家主力机构（基金44家，一般法人4家，QFII1家，信托公司1家），持仓量总计14070.22万股，占流通A股47.72%
其中，基金持仓与2025-06-30相比：
增仓：4家 ，增持 75.10万股
减仓：0家 ，减持 0万股
新出现在主力名单中：40家 ，持有358.33万股
从主力名单中消失：8家 ，原持有30.93万股
其中，基金持仓与2025-06-30相比：
增仓：4家 ，增持 75.10万股
减仓：0家 ，减持 0万股
新出现在主力名单中：40家 ，持有358.33万股
从主力名单中消失：8家 ，原持有30.93万股
消息面诊股
诊断结果：5.2消息面打败了54%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 汉商集团：迪康药业收购拜锐生物 硬核技术赋能运动医
2026-06-05 - 汉商集团终止重大资产交易 内幕知情人自查无违规
2026-06-04 - 汉商集团控股子公司拟增资扩股 3名董事反对
2026-06-04 - 汉商集团子公司引入国资增资5204万元，3名董事联
2026-06-03 - 汉商集团董事会会议又现反对声音，董秘：没有矛盾，站
2026-06-03 - 汉商集团：2026年6月22日召开2026年第二次
2026-06-03 - 汉商集团：公司不存在对控股股东和实际控制人及其关联
2026-06-03 - 汉商集团定增议案遭股东会否决 董事薪酬方案反对率近
2026-05-20 - 汉商集团：拟将回购股份602.41万股注销并减少公
2026-05-19 - 203家医药企业，销售费用来了（附名单）
2026-05-15
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2026-06-04 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-06-04 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-29 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-04-29 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-29 |
| 重大利空 | 业绩预告 | 预计增亏 | 2026-04-22 |
| 重大利空 | 业绩预告 | 预计增亏 | 2026-01-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-29 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 2条 | 2条 | 0条 |
行业面诊股
诊断结果：5.2行业面打败了72%的股票
化学制药行业最新资金流向
近10日来该行业走势总体向下，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，跑输大盘。
[{"date":"2026.06.11","price":"-0.16","value":"-1.24"},{"date":"2026.06.10","price":"-0.42","value":"-0.14"},{"date":"2026.06.09","price":"1.28","value":"0.45"},{"date":"2026.06.08","price":"-1.70","value":"-2.49"},{"date":"2026.06.05","price":"-0.74","value":"0.25"},{"date":"2026.06.04","price":"-0.64","value":"-1.80"},{"date":"2026.06.03","price":"0.22","value":"-1.10"},{"date":"2026.06.02","price":"0.43","value":"-2.06"},{"date":"2026.06.01","price":"-0.27","value":"0.40"},{"date":"2026.05.29","price":"-0.73","value":"0.36"},{"date":"2026.05.28","price":"0.12","value":"-0.71"},{"date":"2026.05.27","price":"-1.25","value":"-1.05"},{"date":"2026.05.26","price":"-0.17","value":"-1.43"},{"date":"2026.05.25","price":"0.96","value":"-1.35"},{"date":"2026.05.22","price":"0.87","value":"0.11"},{"date":"2026.05.21","price":"-2.04","value":"-1.67"},{"date":"2026.05.20","price":"-0.18","value":"-0.92"},{"date":"2026.05.19","price":"0.92","value":"0.64"},{"date":"2026.05.18","price":"-0.09","value":"-1.49"},{"date":"2026.05.15","price":"-1.02","value":"-0.71"},{"date":"2026.05.14","price":"-1.52","value":"-1.71"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 科伦药业 | 21.31% | 12.40% | 6.3分 |
| 2 | 科源制药 | 13.55% | -3.54% | 5.9分 |
| 3 | 通化金马 | 8.63% | 2.39% | 6.1分 |
| 4 | 贝达药业 | 5.71% | 10.16% | 6.1分 |
| 5 | 灵康药业 | 3.16% | 12.29% | 5.9分 |
| 6 | 仙琚制药 | 0.35% | 2.78% | 5.1分 |
| 8 | 纳微科技 | -1.20% | -18.85% | 4.8分 |
| 10 | 天宇股份 | -2.40% | 5.86% | 5.4分 |
| 12 | 东诚药业 | -3.22% | -2.07% | 5.0分 |
| 14 | 赛分科技 | -4.47% | 9.32% | 5.6分 |
| 16 | 华邦健康 | -5.21% | 2.02% | 5.3分 |
| 18 | 共同药业 | -5.64% | -0.23% | 5.0分 |
| 20 | ST惠程 | -6.27% | 3.89% | 5.3分 |
| 22 | 海翔药业 | -6.63% | -6.47% | 5.2分 |
| 24 | 东亚药业 | -7.59% | -11.80% | 5.4分 |
| 26 | 亿帆医药 | -7.76% | -1.60% | 5.1分 |
| 28 | 翰宇药业 | -7.99% | -9.27% | 5.1分 |
| 30 | - | -8.85% | 0.55% | 分 |
| 32 | ST天圣 | -9.06% | -4.38% | 4.9分 |
| 34 | 泽璟制药 | -9.10% | 1.68% | 5.5分 |
| 36 | - | -9.30% | 0.10% | 分 |
| 38 | - | -9.54% | 0.78% | 分 |
| 40 | 天新药业 | -9.96% | -1.24% | 5.3分 |
| 42 | 同和药业 | -10.34% | 2.45% | 5.6分 |
| 44 | - | -10.62% | 1.26% | 分 |
| 46 | 复星医药 | -11.10% | -0.18% | 4.3分 |
| 48 | 中关村 | -11.28% | -2.91% | 5.4分 |
| 50 | 山河药辅 | -11.57% | -0.25% | 4.8分 |
| 52 | 京新药业 | -11.95% | 0.16% | 5.2分 |
| 54 | 金陵药业 | -12.08% | -2.42% | 5.6分 |
| 56 | ST能特 | -12.11% | -0.44% | 4.7分 |
| 58 | 吉贝尔 | -12.32% | -0.29% | 4.9分 |
| 60 | - | -12.51% | -2.21% | 分 |
| 62 | 北大医药 | -12.74% | -1.36% | 5.1分 |
| 64 | 辰欣药业 | -13.08% | -2.10% | 4.6分 |
| 66 | 艾力斯 | -13.28% | -3.68% | 5.1分 |
| 68 | 神奇制药 | -13.39% | -1.82% | 5.8分 |
| 70 | 丰原药业 | -13.85% | -1.46% | 5.5分 |
| 72 | 哈三联 | -13.98% | -2.30% | 5.0分 |
| 74 | 千红制药 | -14.37% | -2.34% | 5.5分 |
| 76 | - | -14.72% | -2.03% | 分 |
| 78 | 鲁抗医药 | -14.84% | -4.50% | 4.0分 |
| 80 | 华海药业 | -14.97% | -6.32% | 4.4分 |
| 82 | 双鹭药业 | -15.18% | -5.18% | 4.5分 |
| 84 | 百利天恒 | -15.60% | 2.57% | 5.1分 |
| 86 | 立方制药 | -15.65% | -3.16% | 5.4分 |
| 88 | 川宁生物 | -15.69% | -1.53% | 4.5分 |
| 90 | 亨迪药业 | -15.86% | -3.00% | 4.8分 |
| 92 | 哈药股份 | -16.03% | -2.52% | 4.9分 |
| 94 | 宏源药业 | -16.18% | -9.29% | 4.9分 |
| 96 | 海正药业 | -16.67% | -0.83% | 4.3分 |
| 98 | 浙江医药 | -17.03% | -2.81% | 4.3分 |
| 100 | 誉衡药业 | -17.13% | -6.67% | 5.4分 |
| 102 | - | -17.57% | -1.62% | 分 |
| 104 | ST复华 | -17.70% | -3.74% | 3.9分 |
| 106 | 常山药业 | -17.88% | -12.09% | 4.6分 |
| 108 | 富士莱 | -18.09% | -2.96% | 4.8分 |
| 110 | 易明医药 | -18.47% | -7.46% | 5.5分 |
| 112 | 康芝药业 | -18.88% | -4.39% | 4.0分 |
| 114 | 海南海药 | -19.02% | -4.53% | 4.8分 |
| 116 | 海森药业 | -19.25% | -0.56% | 4.4分 |
| 118 | 本立科技 | -19.50% | -3.12% | 4.8分 |
| 120 | 微芯生物 | -20.39% | -4.50% | 4.4分 |
| 122 | 润都股份 | -20.88% | -2.75% | 5.1分 |
| 124 | 亚虹医药 | -20.99% | -3.51% | 3.9分 |
| 126 | 华纳药厂 | -21.32% | -7.40% | 4.3分 |
| 128 | 赛托生物 | -21.61% | -2.03% | 5.0分 |
| 130 | 罗欣药业 | -21.84% | -2.39% | 5.2分 |
| 132 | 金城医药 | -22.27% | -4.39% | 5.5分 |
| 134 | 德展健康 | -22.39% | -1.29% | 4.3分 |
| 136 | 前沿生物 | -22.56% | -7.21% | 4.7分 |
| 138 | 新诺威 | -23.17% | -5.33% | 4.9分 |
| 140 | 海创药业 | -23.69% | -11.94% | 4.2分 |
| 142 | 司太立 | -23.92% | -5.55% | 4.3分 |
| 144 | 联环药业 | -24.69% | -7.24% | 4.2分 |
| 146 | 益方生物 | -25.16% | -6.72% | 4.6分 |
| 148 | 舒泰神 | -26.29% | -16.92% | 3.8分 |
| 150 | 博瑞医药 | -28.92% | -6.00% | 4.7分 |
| 152 | 广生堂 | -30.82% | -10.35% | 4.5分 |
| 154 | 迪哲医药 | -32.66% | -8.62% | 4.9分 |
| 156 | 津药药业 | -34.79% | -6.96% | 4.6分 |
| 158 | 上海谊众 | -36.07% | -6.29% | 4.2分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 国信证券 | 2012-09-12 | 增持 | 增持 |
| 国海证券 | 2012-09-11 | 中性 | - |
| 东兴证券 | 2012-09-11 | 增持 | 增持 |
| 平安证券 | 2012-09-10 | 增持 | 增持 |
| 华融证券 | 2012-09-10 | 中性 | 中性 |
更多>>行业资讯
- 2012-09-13海岛建设股东股权质押
- 2012-09-13工大首创简式权益变动
- 2012-09-13华联综超选举公司第五届董事会董事长
- 2012-09-13积极追随政策把握市场热点方向
- 2012-09-13商贸零售行业：行业拐点仍需等待 选择确定性增长公司
- 2012-09-13卡奴迪路调研简报：渠道逆势持续扩张 明年增长新亮点
- 2012-09-13传言家乐福将退出中国市场 专家称可能性甚微
- 2012-09-13外资零售巨头在华遭遇困顿 专家分析八大原因
- 2012-09-13外资零售企业也须与时俱进
- 2012-09-13商务部谈电商价格战：正起草电子商务管理条例
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 119/218 ， 90/218。
[{"date":"2026-03-31","value":"-0.37","vol":"0.43"},{"date":"2025-12-31","value":"-11.11","vol":"-2.03"},{"date":"2025-09-30","value":"0.56","vol":"1.53"},{"date":"2025-06-30","value":"0.10","vol":"1.24"},{"date":"2025-03-31","value":"0.17","vol":"-0.13"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-0.37 | -11.11 | 0.56 | 0.10 | 0.17 |
| 行业(%) | 0.43 | -2.03 | 1.53 | 1.24 | -0.13 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"42.36","vol":"50.72"},{"date":"2025-12-31","value":"47.65","vol":"49.72"},{"date":"2025-09-30","value":"43.61","vol":"49.60"},{"date":"2025-06-30","value":"46.61","vol":"49.57"},{"date":"2025-03-31","value":"45.37","vol":"49.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
42.36 | 47.65 | 43.61 | 46.61 | 45.37 |
| 行业(%) | 50.72 | 49.72 | 49.60 | 49.57 | 49.06 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 122/218 ， 146/218。
[{"date":"2026-03-31","value":"-11.48","vol":"25.51"},{"date":"2025-12-31","value":"-12.23","vol":"38.97"},{"date":"2025-09-30","value":"-15.49","vol":"141.63"},{"date":"2025-06-30","value":"-18.06","vol":"78.56"},{"date":"2025-03-31","value":"-23.51","vol":"0.01"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-11.48 | -12.23 | -15.49 | -18.06 | -23.51 |
| 行业(%) | 25.51 | 38.97 | 141.63 | 78.56 | 0.01 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-297.72","vol":"47.13"},{"date":"2025-12-31","value":"-1098.54","vol":"-26.11"},{"date":"2025-09-30","value":"274.07","vol":"-2.93"},{"date":"2025-06-30","value":"-80.95","vol":"59.61"},{"date":"2025-03-31","value":"-78.21","vol":"-10.40"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-297.72 | -1098.54 | 274.07 | -80.95 | -78.21 |
| 行业(%) | 47.13 | -26.11 | -2.93 | 59.61 | -10.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 106/218 ， 69/218。
[{"date":"2026-03-31","value":"0.07","vol":"0.10"},{"date":"2025-12-31","value":"0.30","vol":"0.41"},{"date":"2025-09-30","value":"0.22","vol":"0.31"},{"date":"2025-06-30","value":"0.15","vol":"0.21"},{"date":"2025-03-31","value":"0.07","vol":"0.10"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.07 | 0.30 | 0.22 | 0.15 | 0.07 |
| 行业(次) | 0.10 | 0.41 | 0.31 | 0.21 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.58","vol":"0.65"},{"date":"2025-12-31","value":"2.25","vol":"2.58"},{"date":"2025-09-30","value":"1.78","vol":"1.93"},{"date":"2025-06-30","value":"1.14","vol":"1.29"},{"date":"2025-03-31","value":"0.56","vol":"0.66"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.58 | 2.25 | 1.78 | 1.14 | 0.56 |
| 行业(次) | 0.65 | 2.58 | 1.93 | 1.29 | 0.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"7.06","vol":"-2.81"},{"date":"2025-12-31","value":"15.42","vol":"16.49"},{"date":"2025-09-30","value":"11.03","vol":"4.26"},{"date":"2025-06-30","value":"19.13","vol":"2.95"},{"date":"2025-03-31","value":"-1.69","vol":"-26.33"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 7.06 | 15.42 | 11.03 | 19.13 | -1.69 |
| 行业 | -2.81 | 16.49 | 4.26 | 2.95 | -26.33 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.21","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.23","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.21 | - | 0.23 | - |
| 行业 | 0.00 | 1.60 | 0.00 | 1.71 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 101/218 ， 74/218。
[{"date":"2026-03-31","value":"0.45","vol":"3.57"},{"date":"2025-12-31","value":"0.46","vol":"3.31"},{"date":"2025-09-30","value":"0.47","vol":"3.48"},{"date":"2025-06-30","value":"0.42","vol":"3.66"},{"date":"2025-03-31","value":"0.46","vol":"3.57"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
0.45 | 0.46 | 0.47 | 0.42 | 0.46 |
| 行业 | 3.57 | 3.31 | 3.48 | 3.66 | 3.57 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.27","vol":"2.93"},{"date":"2025-12-31","value":"0.27","vol":"2.69"},{"date":"2025-09-30","value":"0.27","vol":"2.73"},{"date":"2025-06-30","value":"0.23","vol":"2.88"},{"date":"2025-03-31","value":"0.26","vol":"2.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
0.27 | 0.27 | 0.27 | 0.23 | 0.26 |
| 行业 | 2.93 | 2.69 | 2.73 | 2.88 | 2.80 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 2/218 ， 31/218。
[{"date":"2026-03-31","value":"50.60","vol":"33.54"},{"date":"2025-12-31","value":"50.29","vol":"34.70"},{"date":"2025-09-30","value":"46.72","vol":"34.06"},{"date":"2025-06-30","value":"47.40","vol":"34.12"},{"date":"2025-03-31","value":"49.95","vol":"34.09"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
50.60 | 50.29 | 46.72 | 47.40 | 49.95 |
| 行业(%) | 33.54 | 34.70 | 34.06 | 34.12 | 34.09 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.11","vol":"9.77"},{"date":"2025-12-31","value":"1.10","vol":"1.76"},{"date":"2025-09-30","value":"0.95","vol":"1.19"},{"date":"2025-06-30","value":"0.98","vol":"0.87"},{"date":"2025-03-31","value":"1.08","vol":"1.44"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.11 | 1.10 | 0.95 | 0.98 | 1.08 |
| 行业(%) | 9.77 | 1.76 | 1.19 | 0.87 | 1.44 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"0.90","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.61","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.15","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-1.75","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]